| Re: Hemoglobin / Risk of Death |
| "kuhnfucius" <krkuhn@123adelphia.net> |
| 2006-12-18 17:25:30 |
Damn hemoglobin twill kill youse everytime.
<ironjustice@aol.com> wrote in message
news:1164630945.928483.107070@l12g2000cwl.googlegroups.com...
> <<snip>>
> doctors should aim for lower levels of red blood cells in their
> patients
> <<snip>>
>
> Now seeing that this doctor is describing .. BELOW .. 'accepted lab
> values' .. then this would / should cause a HEADS UP .. in the medical
> community.
>
> Simply because .. the lab values accepted as .. SAFE .. have been shown
> to be linked to increased death.
>
> Soooo .. how many in cardiac care are walking around WITH .. these
> accepted values of .. SAFE .. ?
>
> Probably quite a .. few ..
>
> Seeing that .. 'they' .. are .. EVER PRESENT .. to ENSURE .. you are
> KEPT in this .. state of .. what seems / EVIDENCE based .. to ... KILL
> .. you ..
>
> With friends like these ..
>
> INCREASED risk of death at .. 13.5 .. 14 is considered .. 'normal' ..
>
> http://www.dalesplace.net/lab_values.php#Hematology%20Values
>
> Normal Adult Male Range: 14 - 18 g/dl
>
> http://isopp.org/tiki-print_article.php?articleId=513
>
> FDA ALERT 11/16/2006: FDA is issuing this alert to advise you of a
> newly published clinical study showing that patients treated with an
> erythropoiesis-stimulating agent (ESA) and dosed to a target hemoglobin
> concentration of 13.5 g/dL are at a significantly increased risk for
> serious and life threatening cardiovascular complications, as compared
> to use of the ESA to target a hemoglobin concentration of 11.3 g/dL.
>
> http://tinyurl.com/ylkuwx
>
> US FDA says reviewing J&J anemia drug study
> Wed Nov 15, 2006 7:24pm ET
> WASHINGTON, Nov 15 (Reuters) - U.S. regulators are reviewing a study
> showing kidney disease patients treated more aggressively with Johnson
> & Johnson's (JNJ.N: Quote, Profile, Research) anemia drug Procrit had a
>
> higher risk of cardiac complications, officials said on Wednesday.
>
> http://www.medscape.com/viewarticle/548067
>
> Medscape Alerts
> Higher Target Hemoglobin Levels Linked With Cardiovascular Events
>
> http://www.nytimes.com/2006/11/16/business/16anemia.html?ei=5087%0A&em=&en=03f247998ddb90b9&ex=1163998800&pagewanted=all
>
> Heart Risk Seen in Drug For Anemia
> Print Single-Page Save
>
> By ALEX BERENSON
> Published: November 16, 2006
> A medical study to be released today suggests that high doses of a
> best-selling drug used to treat anemia in dialysis and cancer patients
> may increase the risk of heart problems and deaths
>
> http://www.pharmalive.com/News/index.cfm?articleid=393007
>
> FDA - MedWatch - Erythropoiesis Stimulating Agents - CHOIR Study
> Results Show a Higher Chance of the Combination of Death, Heart Attack,
> Hospitalizations for Heart Failure and Stroke in Patients with Chronic
> Kidney Disease
>
> Who loves ya.
> Tom
>
>
> Jesus Was A Vegetarian!
> http://jesuswasavegetarian.7h.com
>
>
> Man Is A Herbivore!
> http://tinyurl.com/a3cc3
>
>
> DEAD PEOPLE WALKING
> http://tinyurl.com/zk9fk
>
|